Literature DB >> 25838280

CALR-mutated essential thrombocythemia evolving to chronic myeloid leukemia with coexistent CALR mutation and BCR-ABL translocation.

Irina Bonzheim1, Barbara Mankel1, Peter Klapthor2, Janine Schmidt1, Tanja Hinrichsen3, Oliver Wachter3, Falko Fend1, Leticia Quintanilla-Martinez1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25838280     DOI： 10.1182/blood-2014-12-616847

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  Buccal epithelial cells display somatic, bone marrow-derived CALR mutation.

Authors:  Scott R Gilles; Linda B Baughn; Matthew L Schomaker; Elizabeth L Courville; Andrew C Nelson; Zohar Sachs
Journal:  Blood Adv       Date:  2017-11-16

Review 2.  Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.

Authors:  Elisa Rumi; Mario Cazzola
Journal:  Blood       Date:  2016-12-27       Impact factor: 22.113

3.  CALR-positive myeloproliferative disorder in a patient with Ph-positive chronic myeloid leukemia in durable treatment-free remission: a case report.

Authors:  Irene Dogliotti; Carmen Fava; Anna Serra; Enrico Gottardi; Filomena Daraio; Francesca Carnuccio; Emilia Giugliano; Monica Bocchia; Giuseppe Saglio; Giovanna Rege-Cambrin
Journal:  Stem Cell Investig       Date:  2017-06-23

4.  Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR-mutated Essential Thrombocythemia.

Authors:  Anaïse Blouet; Marie-Christine Rousselet; Yannick Le Bris; Bénédicte Ribourtout; Anne Bouvier; Laurane Cottin; Rébecca Jouanneau-Courville; Odile Blanchet; Valérie Ugo; Damien Luque Paz
Journal:  Hemasphere       Date:  2018-02-05

Review 5.  Atypical myeloproliferative neoplasm with concurrent BCR-ABL1 fusion and CALR mutation: A case report and literature review.

Authors:  Chunshui Liu; Ruiping Hu; Zhonghua Du; Manuel Abecasis; Cong Wang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

6.  Concurrent chronic myeloid leukemia and CALR-mutated myeloproliferative neoplasm.

Authors:  Stephen E Langabeer
Journal:  EXCLI J       Date:  2020-01-08       Impact factor: 4.068

Review 7.  Philadelphia+ Chronic Myeloid Leukemia with CALR Mutation: A Case Report and Literature Review.

Authors:  Seug Yun Yoon; Sun Young Jeong; Changgon Kim; Min-Young Lee; Jieun Kim; Kyoung-Ha Kim; Namsu Lee; Jong-Ho Won
Journal:  Cancer Res Treat       Date:  2020-01-15       Impact factor: 4.679
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.